Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Chinese Multi-Center,Randomized Study of Combination or Sequential Use of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy for Node Positive Breast Cancer

NCT00525642 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT00525642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00525642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Chinese Multi-Center,Randomized Study of Combination or Sequential Use of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy for Node Positive Breast Cancer
Lead sponsor
Fudan University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2003
Completion date
June 30, 2015
Enrollment
603 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant, breast neoplasms, chemotherapy